Keywords: Capsugel, Pfizer, KKR, European Commission, Antitrust, Meda, Valeant

EU Commission clears KKR acquisition of Pfizer Capsugel unit; Meda says no approach from Valeant

Article | 28 July 2011

Under European Union merger regulations, the European Commission has cleared the proposed acquisition of Capsugel by fund manager Kohlberg Kravis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in